Chicago Business

Chicago Business

Tempus entering immuno-oncology

Tempus entering immuno-oncology

Having trouble viewing this email? See the online version

Health Pulse Breaking News

Tuesday, July 16, 2024

A lab worker handles vials at a Tempus AI lab

Tempus AI entering the immuno-oncology space

The Chicago-based company's first immune profile score test is now available to researchers.

Did someone forward this to you? Sign up for Health Pulse breaking news alerts here and unlock access to the full story with a Health Pulse subscription.

UNLOCK YOUR ACCESS

Discover the latest insights, analysis & opinion needed to navigate Chicago's complex business landscape.

<![if !mso]> <![endif]>

VIEW OUR SUBSCRIPTION OFFERS

This email was sent to chicagobusinessus627@emails.newslettersbase.com
Manage My Account | Contact Us

© 2024 Crain Communications Inc
130 E. Randolph St., Suite 3200, Chicago, IL 60601 United States
Privacy Policy | Terms and Conditions | Unsubscribe

This email was sent

July 16, 2024 6:53pm
Country:

United States
Tags